GlassScriptPhysician profile
Supraja Reddy Reddy
NPI 1134432479
$7,389.28
in general payments reported to CMS, 2019-2025
63 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $710 · 2021: $1,066 · 2022: $1,343 · 2023: $1,550 · 2024: $1,667 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,614 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,613.98 |
| Education | $114.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,426.11 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Infinity |
| Lilly USA, LLC | $657.20 | 2019-2025 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.32 | 2020-2025 | Jardiance, Synjardy, Glyxambi |
| Novo Nordisk INC | $454.94 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $306.74 | 2020-2025 | Farxiga |
| Dexcom, INC. | $300.33 | 2019-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $206.64 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Medtronic, INC. | $199.22 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Inceptiv |
| Sanofi-Aventis U.S. LLC | $187.59 | 2020-2024 | |
| Medtronic Minimed, INC. | $142.48 | 2019-2020 | |
| Mannkind Corporation | $133.74 | 2019-2025 | Afrezza |
| Amarin Pharma, INC. | $128.05 | 2019-2022 | |
| Amgen INC. | $127.42 | 2020-2025 | Evenity, Uplizna, Prolia |
| Corcept Therapeutics | $125.02 | 2020-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $122.02 | 2021-2024 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $118.46 | 2019-2021 | |
| Ucb, INC. | $117.62 | 2020-2024 | Rystiggo, Briviact |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.70 | 2019-2022 | |
| Sk Life Science, INC. | $115.83 | 2020-2022 | |
| Argenx US, INC. | $105.85 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Genzyme Corporation | $104.61 | 2020-2021 | |
| Abbvie INC. | $91.16 | 2020-2023 | |
| Beta Bionics, INC. | $89.50 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ibsa Pharma INC. | $84.67 | 2021-2024 | Tirosint, Licart, Tirosint |
| Janssen Pharmaceuticals, INC | $79.95 | 2019-2022 | |
| Gilead Sciences, INC. | $78.96 | 2020-2021 | |
| Ge Healthcare | $74.15 | 2019-2022 | |
| Biogen, INC. | $59.63 | 2022 | |
| Ascensia Diabetes Care US INC. | $58.26 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $55.82 | 2022-2025 | Austedo Xr, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $52.01 | 2023 | Camzyos |
| Vanda Pharmaceuticals INC. | $50.45 | 2020-2021 | |
| Eisai INC. | $50.11 | 2020-2021 | |
| Intercept Pharmaceuticals, INC. | $49.58 | 2020 | |
| Antares Pharma, INC. | $49.29 | 2021-2022 | |
| Kyowa Kirin, INC. | $48.58 | 2019-2022 | |
| Braintree Laboratories, INC. | $45.51 | 2020-2021 | |
| Intuity Medical INC | $42.50 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Nevro Corp. | $41.96 | 2023 | Senza |
| Novartis Pharmaceuticals Corporation | $40.75 | 2022-2025 | |
| Radius Health, INC. | $36.48 | 2024-2025 | Tymlos |
| Alexion Pharmaceuticals, INC. | $36.47 | 2022-2023 | Strensiq |
| Grifols USA, LLC | $35.90 | 2019-2023 | Gamunex-C |
| Insulet Corporation | $34.57 | 2019 | |
| Verity Pharmaceuticals INC. | $31.80 | 2024 | Tlando |
| Upsher-Smith Laboratories LLC | $30.51 | 2020-2021 | |
| Janssen Biotech, INC. | $28.46 | 2021 | |
| Ironwood Pharmaceuticals, INC | $28.42 | 2020 | |
| Akcea Therapeutics, INC. | $28.13 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $27.55 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $27.27 | 2019-2022 | |
| Becton, Dickinson and Company | $26.72 | 2021 | |
| Sumitomo Pharma America, INC. | $23.52 | 2023 | Aptiom |
| Corium, LLC | $22.29 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $21.04 | 2024 | |
| Neurelis, INC. | $19.02 | 2024 | Valtoco |
| Lundbeck LLC | $18.68 | 2023 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $16.94 | 2021 | |
| Amneal Pharmaceuticals LLC | $15.72 | 2021 | |
| Amryt Pharma Holdings LTD | $15.03 | 2021 | |
| Sequel Med Tech, LLC | $14.76 | 2025 | Twiist |
| Acerus Pharmaceuticals Corporation | $14.21 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supraja Reddy Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.